HUE068300T2 - Pridopidin törékeny X szindróma kezelésében történõ alkalmazásra - Google Patents
Pridopidin törékeny X szindróma kezelésében történõ alkalmazásraInfo
- Publication number
- HUE068300T2 HUE068300T2 HUE18741607A HUE18741607A HUE068300T2 HU E068300 T2 HUE068300 T2 HU E068300T2 HU E18741607 A HUE18741607 A HU E18741607A HU E18741607 A HUE18741607 A HU E18741607A HU E068300 T2 HUE068300 T2 HU E068300T2
- Authority
- HU
- Hungary
- Prior art keywords
- pridopidine
- fragile
- syndrome
- treatment
- Prior art date
Links
- 208000001914 Fragile X syndrome Diseases 0.000 title 1
- YGKUEOZJFIXDGI-UHFFFAOYSA-N pridopidine Chemical compound C1CN(CCC)CCC1C1=CC=CC(S(C)(=O)=O)=C1 YGKUEOZJFIXDGI-UHFFFAOYSA-N 0.000 title 1
- 229950003764 pridopidine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762448595P | 2017-01-20 | 2017-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE068300T2 true HUE068300T2 (hu) | 2024-12-28 |
Family
ID=62908348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18741607A HUE068300T2 (hu) | 2017-01-20 | 2018-01-18 | Pridopidin törékeny X szindróma kezelésében történõ alkalmazásra |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11234973B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3570940B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7114604B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110505902B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018210145B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019015000A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3050700C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3570940T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2972205T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE068300T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL268125B2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3570940T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018136600A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013536825A (ja) | 2010-09-03 | 2013-09-26 | イバックス・インターナショナル・ゲーエムベーハー | ドパミン作動性安定化剤として有用なプリドピジンの重水素化類似体 |
| US11090297B2 (en) | 2013-06-21 | 2021-08-17 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating huntington's disease |
| EP3503890B1 (en) | 2016-08-24 | 2024-12-18 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating dystonias |
| MX390627B (es) | 2016-08-24 | 2025-03-21 | Prilenia Neurotherapeutics Ltd | Uso de pridopidina para el tratamiento de la disminucion funcional. |
| US12102627B2 (en) | 2016-09-16 | 2024-10-01 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine for treating rett syndrome |
| US12036213B2 (en) | 2017-09-08 | 2024-07-16 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating drug induced dyskinesias |
| CN111343982A (zh) | 2017-09-08 | 2020-06-26 | 普瑞尼亚神经治疗有限公司 | 用于治疗药物诱发的异动症的普利多匹定 |
| BR112021015346A2 (pt) | 2019-02-04 | 2021-10-05 | Prilenia Neurotherapeutics Ltd. | Uso de pridopidina de baixa dose para a doença de parkinson e outras doenças associadas ao parkinsonismo |
| JP7490064B2 (ja) * | 2020-01-08 | 2024-05-24 | ニューロヴェンティ カンパニー リミテッド | リスリード化合物を有効成分として含む脆弱ｘ症候群または関連発達障害治療用組成物 |
| CN116472043A (zh) * | 2020-10-20 | 2023-07-21 | 普瑞尼亚神经治疗有限公司 | 普利多匹定和类似物用于治疗焦虑和抑郁的用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| CA2584831C (en) | 2004-10-13 | 2013-09-17 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
| WO2008127188A1 (en) | 2007-04-12 | 2008-10-23 | Allbay Ab | N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles |
| TW200848063A (en) * | 2007-04-23 | 2008-12-16 | Combinatorx Inc | Methods and compositions for the treatment of neurodegenerative disorders |
| JP2013532233A (ja) | 2010-07-02 | 2013-08-15 | アクティエボラゲット・エスコーエッフ | 機械構成要素、および表面硬化方法 |
| JP2013536825A (ja) | 2010-09-03 | 2013-09-26 | イバックス・インターナショナル・ゲーエムベーハー | ドパミン作動性安定化剤として有用なプリドピジンの重水素化類似体 |
| PL2667715T3 (pl) * | 2011-01-27 | 2018-02-28 | Neuren Pharmaceuticals Limited | Leczenie zaburzeń spektrum autystycznego z wykorzystaniem kwasu glicylo-l- 2-metyloprolilo-l-glutaminowego |
| EP2753603B1 (en) | 2011-09-07 | 2017-06-21 | Teva Pharmaceuticals International GmbH | Polymorphic form of pridopidine hydrochloride |
| WO2013086425A1 (en) | 2011-12-08 | 2013-06-13 | IVAX International GmbH | The hydrobromide salt of pridopidine |
| US20130267552A1 (en) | 2012-04-04 | 2013-10-10 | IVAX International GmbH | Pharmaceutical compositions for combination therapy |
| CN104768545A (zh) * | 2012-09-27 | 2015-07-08 | 泰华制药工业有限公司 | 雷沙吉兰和普多比啶组合以治疗神经退化性病症,尤其亨廷顿氏病 |
| UA122999C2 (uk) | 2013-06-21 | 2021-02-03 | Прайлінія Н'Юротерапьютікс Лтд. | Застосування придопідину для лікування хвороби гантінгтона |
| JP6949487B2 (ja) | 2014-01-22 | 2021-10-13 | プリレニア・ニューロセラピューティクス・エルティーディーＰｒｉｌｅｎｉａ Ｎｅｕｒｏｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ | プリドピジンの調節放出製剤 |
| TW201613859A (en) | 2014-06-30 | 2016-04-16 | Teva Pharma | Analogs of PRIDOPIDINE, their preparation and use |
| CA2970799A1 (en) | 2014-12-22 | 2016-06-30 | Teva Pharmaceuticals International Gmbh | L-tartrate salt of pridopidine |
| EP4282479A3 (en) | 2015-02-25 | 2024-02-21 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to treat depression or anxiety |
| WO2016138135A1 (en) | 2015-02-25 | 2016-09-01 | Teva Pharmaceuticals International Gmbh | Sigma-1 receptor modulators for treating huntington's disease |
-
2018
- 2018-01-18 HU HUE18741607A patent/HUE068300T2/hu unknown
- 2018-01-18 AU AU2018210145A patent/AU2018210145B2/en active Active
- 2018-01-18 IL IL268125A patent/IL268125B2/en unknown
- 2018-01-18 BR BR112019015000A patent/BR112019015000A2/pt not_active Application Discontinuation
- 2018-01-18 EP EP18741607.8A patent/EP3570940B1/en active Active
- 2018-01-18 WO PCT/US2018/014169 patent/WO2018136600A1/en not_active Ceased
- 2018-01-18 DK DK18741607.8T patent/DK3570940T3/da active
- 2018-01-18 PL PL18741607.8T patent/PL3570940T3/pl unknown
- 2018-01-18 JP JP2019539958A patent/JP7114604B2/ja active Active
- 2018-01-18 CN CN201880007913.2A patent/CN110505902B/zh active Active
- 2018-01-18 CA CA3050700A patent/CA3050700C/en active Active
- 2018-01-18 ES ES18741607T patent/ES2972205T3/es active Active
-
2019
- 2019-07-17 US US16/514,167 patent/US11234973B2/en active Active
-
2022
- 2022-01-31 US US17/588,403 patent/US20220202798A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7114604B2 (ja) | 2022-08-08 |
| CN110505902B (zh) | 2022-11-11 |
| IL268125B2 (en) | 2023-04-01 |
| EP3570940A4 (en) | 2020-10-28 |
| PL3570940T3 (pl) | 2024-06-17 |
| EP3570940B1 (en) | 2023-12-13 |
| IL268125B (en) | 2022-12-01 |
| DK3570940T3 (da) | 2024-02-19 |
| US20220202798A1 (en) | 2022-06-30 |
| WO2018136600A1 (en) | 2018-07-26 |
| US20190336488A1 (en) | 2019-11-07 |
| BR112019015000A2 (pt) | 2020-04-07 |
| CA3050700A1 (en) | 2018-07-26 |
| EP3570940A1 (en) | 2019-11-27 |
| AU2018210145B2 (en) | 2023-06-29 |
| AU2018210145A1 (en) | 2019-08-29 |
| JP2020514313A (ja) | 2020-05-21 |
| IL268125A (en) | 2019-09-26 |
| CN110505902A (zh) | 2019-11-26 |
| CA3050700C (en) | 2023-10-03 |
| US11234973B2 (en) | 2022-02-01 |
| ES2972205T3 (es) | 2024-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273495A (en) | Treatment of fragile X syndrome with cannabidiol | |
| GB2548873B (en) | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome | |
| HUE068300T2 (hu) | Pridopidin törékeny X szindróma kezelésében történõ alkalmazásra | |
| IL258964A (en) | Thin and flexible absorbent items | |
| IL250016A0 (en) | Antisense oligonucleotides for the treatment of type 2 syndrome | |
| IL258962A (en) | Thin and flexible absorbent items | |
| GB2574762B (en) | Absorbent article | |
| GB201621480D0 (en) | Use of cannabinoids in the treatment of angelman syndrome | |
| IL258963A (en) | Thin and flexible absorbent items | |
| GB2574984B (en) | Thong-style absorbent article | |
| IL272163B1 (en) | Imatelastat for use in the treatment of myelodysplastic syndrome | |
| SG11202004898VA (en) | Underpants-shaped absorbent article | |
| GB2581058B (en) | Absorbent article | |
| SG11202000921XA (en) | Absorbent article | |
| GB2581054B (en) | Absorbent article | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| ZA202003100B (en) | Absorbent article component | |
| PL3716927T3 (pl) | Wyrób chłonny | |
| HUE066511T2 (hu) | Készítmények hunter-szindróma kezelésére | |
| GB2581084B (en) | Absorbent article | |
| GB202017373D0 (en) | Absorbent article | |
| SG11202000922VA (en) | Absorbent article | |
| PL3691592T3 (pl) | Wyrób chłonny | |
| CA186507S (en) | Absorbent article | |
| CA186508S (en) | Absorbent article |